Former Poniard Pharmaceuticals CEO Ron Martell replaced the retired Tony DiTonno as president and CEO of pain treatment developer NeurogesX Inc.
Martell’s base salary is $460,000, compared to a 2010 base salary of $440,214 at Poniard. He also will receive an annual target performance bonus at NeurogesX of 50 percent of the base and an option to buy 500,000 shares.
No comments:
Post a Comment